Given the role of the NKA-Src complex in the pathogenesis of renal injury and fibrosis, these findings suggest that the NKA and CD40 may be a part of profibrotic signaling in the kidney and inhibition of this pathway may be useful in the treatment of renal fibrosis. This evidence concerns the gene TAC1 and renal fibrosis.